Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q4 2025 holdings
- Shares (Q4 2025)
- 2,050
- Value
- $104.3K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 2,050 | $104.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,050 | $113.8K | <0.1% | −144−6.6% | Reduced | Holders |
| Q2 2025 | 2,194 | $151.4K | <0.1% | +58+2.7% | Added | Holders |
| Q1 2025 | 2,136 | $148.3K | <0.1% | −158−6.9% | Reduced | Holders |
| Q4 2024 | 2,294 | $197.3K | <0.1% | +50+2.2% | Added | Holders |
| Q3 2024 | 2,244 | $267.2K | 0.1% | −34−1.5% | Reduced | Holders |
| Q2 2024 | 2,278 | $325.2K | 0.1% | +192+9.2% | Added | Holders |
| Q1 2024 | 2,086 | $267.8K | 0.1% | +2,000+2,325.6% | Added | Holders |
| Q4 2023 | 86 | $8.90K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 86 | $7.82K | <0.1% | 00.0% | UnchangedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 43 | $6.96K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 43 | $6.84K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 43 | $5.82K | <0.1% | −48−52.7% | Reduced | Holders |
| Q3 2022 | 91 | $9.07K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 91 | $10.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 91 | $10.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 91 | $10.2K | <0.1% | – | No prior filing | Holders |